Docusign (NASDAQ: DOCU) will be reporting their first quarter 2022 financial results today after market close. Analysts have a consensus $273.06 12-month price target on the company, via a total of 19 analysts, with nine analysts having strong buy ratings, eight analysts having buy ratings, and two have hold ratings. The street high comes in at a $300 price target from Oppenheimer, and the lowest target sits at $210 from Wells Fargo.
13 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 13 analysts is $437.81 million; this number has been revised upwards from $421.12 million at the start of the year. The highest revenue estimate is $454.1 million, while the lowest is $432.83 million.
The analyst consensus for net income for the first quarter is $56.12 million, this is up from the start of the year, when it sat at $41.14 million. The highest net income estimate is $60.90 million, while the lowest is $36.50 million.
Onto EBITDA estimates, there are currently only 7 analysts who have first quarter EBITDA estimates. The mean is currently $73.81 million, with this number having been revised higher from $51.94 million at the start of the year. The street high estimate currently sits at $77 million in EBITDA and the lowest is $65.59 million.
Analysts estimate that quarterly earnings per share will come in at ($0.20), with this number being higher from the ($0.30) estimate at the start of the year. The street high is ($0.03) and the lowest estimate is ($0.32) per share for the quarter.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
